2026 年化工行业策略报告 20251224 摘要 AI 技术驱动化工产品需求增长，尤其在冷却液和电力设备等领域，为化 工行业带来新的增长点。中国化工龙头企业通过技术进步和成本控制， 在周期底部仍保持较高利润水平，尤其在欧洲能源成本上升背景下，中 国企业有望创造净自由现金流。 国内反内卷政策限制新增产能，推动 PD 涤纶长丝、草甘膦、有机硅等 领域减少过度竞争，促使亏损企业回归合理盈利水平，为行业带来价值 重估机会。中国基础化工行业上市公司净利率维持在 6-7%左右，资产 负债率处于历史低位，约为 48%，显示出强大的现金流能力。 全球化工行业进入低速增长阶段，预计到 2026 年全球在建工程占固定 资产比例将回落至 20%左右。中国占据全球 50%的产能，欧洲占 20%，欧洲产能退出加速，全球化工产业呈现供给端增速放缓、需求拉 动持续增强的态势。 中国化工行业现金流量和固定资产开支处于下行周期，预计未来固定资 产开支将下降到 1,500 亿以内，现金流净额有望达到 1,000 亿左右，龙 头企业具备较高的分红能力，2026 年理论股息率可能达到 10%至 20%。 Q&A 中国化工行业在未来几年内的资本支 ...

股票简称 股票代码 限售股类型 解禁股数 广东宏大 002683 股权激励限售流通 447.03万 智通财经APP获悉，12月25日共有1家上市公司的限售股解禁，解禁总市值约8770.66万元。 今日具体限售解禁股情况如下： ...

Group 1: Overseas News - US stock market has seen five consecutive days of gains, with the Dow Jones up 0.6%, Nasdaq up 0.22%, and S&P 500 up 0.32%. Major tech companies like Apple, Meta, Microsoft, and Amazon saw increases of up to 0.53%, while Tesla, Google A, and Nvidia experienced declines of up to 0.32% [1] - Nvidia denied reports of a $200 million acquisition of AI chip startup Groq, stating that only a licensing agreement for inference technology was reached [1] - Samsung and SK Hynix are reportedly raising HBM3E prices by nearly 20% for next year [1] - Sanofi plans to acquire US vaccine company Dynavax for $2.2 billion to enhance its adult vaccine portfolio [1] Group 2: Domestic Major Events - The People's Bank of China and eight other departments issued opinions to support the construction of the Western Land-Sea New Corridor, exploring cross-border payment trials for digital RMB with Singapore [2][5] Group 3: Market Strategy Insights - Everbright Securities noted that the Shanghai Composite Index has shown strong performance with six consecutive days of gains, indicating a recovery in market sentiment and potential continued inflow of funds, particularly favoring technology growth stocks [3] Group 4: Real Estate Policy Changes - Beijing's new real estate policy, effective December 24, 2025, includes four main aspects: relaxing social security requirements for non-Beijing residents, supporting multi-child families in housing needs, optimizing commercial loan interest rates, and lowering the down payment ratio for second homes [4][5] Group 5: Digital Currency Developments - The digital RMB aims to address inefficiencies and high costs in traditional cross-border payments, with optimistic projections for transaction volumes reaching 162.4 trillion yuan by 2030 [6]

Group 1 - On December 25, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 247 million shares, amounting to a market value of 6.273 billion yuan based on the latest closing price [1] - The companies with the highest unlock volumes were Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda, with unlock shares of 222 million, 17.84 million, and 4.4287 million respectively [1] - In terms of unlock market value, Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda led with market values of 5.721 billion yuan, 304 million yuan, and 182 million yuan respectively [1] Group 2 - The companies with the highest unlock ratios relative to their total share capital were Mousse Co., Ltd., Shengda Biology, and Keda Control, with unlock ratios of 50.92%, 9.44%, and 1.42% respectively [1]

Summary of Key Points Core Viewpoint - On December 25, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 247 million shares, amounting to a market value of 6.273 billion yuan based on the latest closing prices [1]. Group 1: Unlock Volume - The companies with the highest unlock volumes were Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda, with unlock shares of 222 million, 17.84 million, and 4.4287 million respectively [1]. Group 2: Unlock Market Value - In terms of unlock market value, Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda led the way, with unlock market values of 5.721 billion yuan, 304 million yuan, and 18.2 million yuan respectively [1]. Group 3: Unlock Ratio - Regarding the proportion of unlock shares to total share capital, Mousse Co., Ltd., Shengda Biology, and Keda Control had the highest unlock ratios, at 50.92%, 9.44%, and 1.42% respectively [1].

Core Viewpoint - The company has approved the first unlock period of its 2023 restricted stock incentive plan, allowing 326 eligible participants to unlock a total of 4,428,745 shares, which represents 0.5827% of the company's total share capital, effective December 25, 2025 [2][3][8]. Group 1: Incentive Plan Implementation - The company held its sixth board meeting on December 5, 2025, where it approved the achievement of conditions for the first unlock period of the 2023 restricted stock incentive plan [3][10]. - The first unlock period for the restricted stock will expire on December 24, 2025, with the shares granted on November 30, 2023, and listed on December 25, 2023 [7][8]. - The total number of eligible participants for the unlock is 326, with 4,428,745 shares available for unlocking [2][8]. Group 2: Adjustments and Approvals - The company received approval from the Guangdong Provincial Government's State-owned Assets Supervision and Administration Commission for the 2023 restricted stock incentive plan on September 27, 2023 [4]. - The number of incentive participants was adjusted from 407 to 331, and the total shares granted were reduced from 14,795,176 to 12,133,923 [5]. - The company announced the public disclosure of the incentive object list on November 1, 2023, and held a shareholder meeting on November 7, 2023, to approve the revised incentive plan [4][5]. Group 3: Unlock Conditions and Compliance - The unlock conditions for the restricted stock are based on the performance assessment of the individual and their respective business unit [7][8]. - The board's remuneration and assessment committee confirmed that the eligible participants meet the conditions for unlocking as per the incentive plan's management measures [11]. - Legal opinions confirm that the unlock conditions have been met and necessary approvals obtained, ensuring compliance with relevant laws and regulations [12][13].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002683 证券简称：广东宏大 公告编号：2025-090 广东宏大控股集团股份有限公司 关于2023年限制性股票激励计划第一个解除限售期解除限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、本次符合解除限售条件的激励对象共计326人，可解除限售股份数量为4,428,745股，占公司当前总股 本的0.5827%。 2、本次解除限售股份上市流通日为2025年12月25日。 广东宏大控股集团股份有限公司（以下简称"公司"）于2025年12月5日召开了第六届董事会2025年第十 二次会议，审议通过了《关于2023年限制性股票激励计划第一个解除限售期解除限售条件成就的议 案》，鉴于公司2023年限制性股票激励计划的第一个解除限售期解除限售条件已经成就，根据公司2023 年第四次临时股东大会的授权，现拟按照规定为本次限制性股票激励对象办理第一次解除限售相关事 宜。本次符合解除限售条件的激励对象人数为326人，可解除限售股份数量为4,428,745股，占公司当前 总股 ...

证券日报网讯 12月21日晚间，广东宏大发布公告称，公司2023年限制性股票激励计划第一个解除限售 期解除限售条件已成就，本次符合解除限售条件的激励对象共计326人，可解除限售股份数量为4， 428，745股，占公司当前总股本的0.5827%。上市流通日为2025年12月25日。 （编辑 王江浩） ...

证券代码：002683 证券简称：广东宏大 公告编号：2025-090 2、本次解除限售股份上市流通日为 2025 年 12 月 25 日。 广东宏大控股集团股份有限公司（以下简称"公司"）于 2025 年 12 月 5 日召开了第六届董事会 2025 年第十二次会议，审议通过了 《关于 2023 年限制性股票激励计划第一个解除限售期解除限售条件 成就的议案》，鉴于公司 2023 年限制性股票激励计划的第一个解除 限售期解除限售条件已经成就，根据公司 2023 年第四次临时股东大 会的授权，现拟按照规定为本次限制性股票激励对象办理第一次解除 限售相关事宜。本次符合解除限售条件的激励对象人数为 326 人，可 解除限售股份数量为 4,428,745 股，占公司当前总股本的 0.5827%。 上述可解除限售股份的上市流通日为 2025 年 12 月 25 日。具体情况 如下： 一、公司本次限制性股票激励计划实施情况 广东宏大控股集团股份有限公司 关于 2023 年限制性股票激励计划第一个解除限售期 解除限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈 ...

证券日报网讯12月19日晚间，广东宏大（002683）发布公告称，公司及控股子公司无逾期对外担保，也 无涉及诉讼的对外担保及因担保被判决败诉而应承担损失的情形。 ...